A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Clinical trial NCT06925724 · RECRUITING
Trial details
- NCT number
- NCT06925724
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-04
- Primary completion
- 2027-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.